Monoclonal antibodies in cancer therapy. Journal of Clinical Oncology. 1983; 1: 582-590 Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs. Acc Chem Res. 2008; 41: 98-107 Pegram M.D. Pauletti G. Slamon D.J. Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy. Breast Cancer Res Treat. 1998; 52: 65-77 Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer. New England Journal of Medicine.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Pietro
Contact Pietro, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack